ZS Pharma, Inc. Capital Expenditures
ZS Pharma, Inc. reported Capital Expenditures of $6.32 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2015-11-09
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2015-09-30 was $4.56M, a 126.00% increase year-over-year.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2015-06-30 was $892.00K, a 66.60% decline year-over-year.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2015-03-31 was $869.00K, a 18.10% decline year-over-year.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2014-12-31 was $2.25M, a 456.44% increase year-over-year.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $8.00M, a 112.12% increase from fiscal 2013.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2013 was $3.77M, a 434.14% increase from fiscal 2012.
- ZS Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2012 was $706.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2015-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.46M derived: sum of 2 quarters · filed 2015-11-09 | $6.32M 10-Q · filed 2015-11-09 | $8.57M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | $892.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.76M 10-Q · filed 2015-08-06 | $4.01M derived: sum of 3 quarters · filed 2015-08-06 | $6.03M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $869.00K 10-Q · filed 2015-05-11 | $3.12M derived: sum of 2 quarters · filed 2015-05-11 | $5.14M derived: sum of 3 quarters · filed 2015-11-09 | $7.81M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $4.27M derived: sum of 2 quarters · filed 2015-11-09 | $6.94M derived: sum of 3 quarters · filed 2015-11-09 | $8.00M 10-K · filed 2015-03-13 |
| 2014-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.69M derived: sum of 2 quarters · filed 2015-11-09 | $5.75M 10-Q · filed 2015-11-09 | $6.16M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $3.73M 10-Q · filed 2015-08-06 | $4.14M derived: sum of 3 quarters · filed 2015-08-06 | $5.34M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $1.06M 10-Q · filed 2015-05-11 | $1.47M derived: sum of 2 quarters · filed 2015-05-11 | $2.67M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.61M derived: sum of 2 quarters · filed 2015-03-13 | $3.77M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $3.37M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $2.16M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $706.00K 10-K · filed 2015-03-13 |